Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 10.26 Delayed Data As of 3:59pm ET |  -0.095 / -0.92%Today’s Change | 7.09 Today|||52-Week Range 11.45 | +12.45% Year-to-Date |
Latest TEVA News | Press Releases
| Unveiling Teva Pharmaceutical Industries (TEVA)'s Value: Is It Really Priced Right? A ... Sep 20 / GuruFocus News - Paid Partner Content | 3 No-Brainer Stocks to Buy With $20 Right Now Sep 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.35 |
| Today’s open | 10.34 |
| Day’s range | 10.04 - 10.34 |
| Volume | 6,711,988 |
| Average volume (3 months) | 11,842,812 |
| Market cap | $11.6B |
Data as of 3:59pm ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | -660.20% |
| Earnings growth (this year) | -9.18% |
| Earnings growth (next 5 years) | +3.40% |
| Revenue growth (last year) | -5.89% |
| P/E ratio | NM |
| Price/Sales | 0.68 |
| Price/Book | 1.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeigene Ltd | -0.07 | -0.04% |
| BBIOBridgeBio Pharma Inc | -0.16 | -0.59% |
| IDRSFIdorsia Ltd | -1.10 | -26.83% |
| ---- |
Data as of 4:00pm ET, 09/25/2023
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $14.9B |
| Annual profit (last year) | -$2.4B |
| Net profit margin | -15.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Tel Aviv, Tel Aviv |
Forecasts
